In Vitro Maturation (IVM) of Human Immature Oocytes: is It Still Relevant?

Overview

Journal Reprod Biol Endocrinol

Publisher Biomed Central

Specialties Endocrinology
Reproductive Medicine

Date 2023 Nov 23

PMID 37993914

Authors

Mausumi Das

Weon-Young Son

Affiliations

Soon will be listed here.

Abstract

In vitro maturation (IVM) of human immature oocytes has been shown to be a viable option for patients at risk of ovarian hyperstimulation syndrome (OHSS), those seeking urgent fertility preservation and in circumstances where controlled ovarian stimulation is not feasible. Moreover, IVM techniques can be combined with ovarian tissue cryobanking to increase the chances of conception in cancer survivors. The clinical applications of IVM in the field of reproductive medicine are rapidly expanding and the technique is now classified as non-experimental. In contrast to conventional IVF (in vitro fertilization), IVM offers several advantages, such as reduced gonadotropin stimulation, minimal risk of ovarian hyperstimulation syndrome (OHSS), reduced treatment times and lower costs. However, the technical expertise involved in performing IVM and its lower success rates compared to traditional IVF cycles, still pose significant challenges. Despite recent advances, such as innovative biphasic IVM systems, IVM is still an evolving technique and research is ongoing to refine protocols and identify techniques to improve its efficiency and effectiveness. A comprehensive understanding of the distinct mechanisms of oocyte maturation is crucial for obtaining more viable oocytes through in vitro methods, which will in turn lead to significantly improved success rates. In this review, the present state of human IVM programs and future research directions will be discussed, aiming to promote a better understanding of IVM and identify potential strategies to improve the overall efficiency and success rates of IVM programs, which will in turn lead to better clinical outcomes.

Citing Articles

Oocytes with impaired meiotic maturation contain increased mtDNA deletions.

Kofinas J, Seth-Smith M, Kramer Y, Van Daele J, McCulloh D, Wang F J Assist Reprod Genet. 2025; .

PMID: 39863755 DOI: 10.1007/s10815-025-03393-w.

New aspect on the regulation of in vitro oocyte maturation: role of the obesity, neuropeptides and adipokines.

Kurowska P, Wyroba J, Pich K, Respekta-Dlugosz N, Szkraba O, Greggio A J Assist Reprod Genet. 2024; .

PMID: 39671071 DOI: 10.1007/s10815-024-03345-w.

Endometriosis: A Comprehensive Exploration of Inflammatory Mechanisms and Fertility Implications.

Rathod S, Shanoo A, Acharya N Cureus. 2024; 16(8):e66128.

PMID: 39229427 PMC: 11370979. DOI: 10.7759/cureus.66128.

Mature oocyte found during ovarian tissue cryopreservation in an early adolescent female.

Zhang H, Shi L, Wang H, Zhu H Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(4):527-530.

PMID: 39183059 PMC: 11375484. DOI: 10.3724/zdxbyxb-2023-0561.

Exploring the Potential of Maturation (IVM) of Oocytes: Indications, Applications, and Treatment Protocols.

Torkashvand H, Shabani R, Amiri I, Darakhshan R, Maleki B, Doostabadi M Avicenna J Med Biotechnol. 2024; 16(3):156-164.

PMID: 39132634 PMC: 11316506. DOI: 10.18502/ajmb.v16i3.15741.

References

Camaioni A, Salustri A, Yanagishita M, Hascall V . Proteoglycans and proteins in the extracellular matrix of mouse cumulus cell-oocyte complexes. Arch Biochem Biophys. 1996; 325(2):190-8. DOI: 10.1006/abbi.1996.0024. View

De Vos M, Grynberg M, Ho T, Yuan Y, Albertini D, Gilchrist R . Perspectives on the development and future of oocyte IVM in clinical practice. J Assist Reprod Genet. 2021; 38(6):1265-1280. PMC: 8266966. DOI: 10.1007/s10815-021-02263-5. View

Vanhoutte L, Nogueira D, Dumortier F, De Sutter P . Assessment of a new in vitro maturation system for mouse and human cumulus-enclosed oocytes: three-dimensional prematuration culture in the presence of a phosphodiesterase 3-inhibitor. Hum Reprod. 2009; 24(8):1946-59. DOI: 10.1093/humrep/dep104. View

Ho V, Pham T, Le A, Ho T, Vuong L . Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome. J Ovarian Res. 2018; 11(1):70. PMC: 6112143. DOI: 10.1186/s13048-018-0445-5. View

Junk S, Yeap D . Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome. Fertil Steril. 2012; 98(4):888-92. DOI: 10.1016/j.fertnstert.2012.06.055. View

Huang J, Tulandi T, Holzer H, Tan S, Chian R . Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril. 2007; 89(3):567-72. DOI: 10.1016/j.fertnstert.2007.03.090. View

Ben-Haroush A, Sapir O, Fisch B . Aspiration of immature oocytes during cesarean section for fertility preservation and future surrogacy. Am J Obstet Gynecol. 2010; 203(1):e12-4. DOI: 10.1016/j.ajog.2010.04.011. View

Chen L, Wert S, Hendrix E, Russell P, Cannon M, Larsen W . Hyaluronic acid synthesis and gap junction endocytosis are necessary for normal expansion of the cumulus mass. Mol Reprod Dev. 1990; 26(3):236-47. DOI: 10.1002/mrd.1080260307. View

Conti M, Hsieh M, Park J, Su Y . Role of the epidermal growth factor network in ovarian follicles. Mol Endocrinol. 2005; 20(4):715-23. DOI: 10.1210/me.2005-0185. View

10.

Nikiforov D, Junping C, Cadenas J, Shukla V, Blanshard R, Pors S . Improving the maturation rate of human oocytes collected ex vivo during the cryopreservation of ovarian tissue. J Assist Reprod Genet. 2020; 37(4):891-904. PMC: 7183016. DOI: 10.1007/s10815-020-01724-7. View

11.

Gilchrist R, Nayudu P, Hodges J . Maturation, fertilization, and development of marmoset monkey oocytes in vitro. Biol Reprod. 1997; 56(1):238-46. DOI: 10.1095/biolreprod56.1.238. View

12.

Tornell J, Billig H, Hillensjo T . Regulation of oocyte maturation by changes in ovarian levels of cyclic nucleotides. Hum Reprod. 1991; 6(3):411-22. DOI: 10.1093/oxfordjournals.humrep.a137351. View

13.

Salustri A, Ulisse S, Yanagishita M, Hascall V . Hyaluronic acid synthesis by mural granulosa cells and cumulus cells in vitro is selectively stimulated by a factor produced by oocytes and by transforming growth factor-beta. J Biol Chem. 1990; 265(32):19517-23. View

14.

Walls M, Hart R . In vitro maturation. Best Pract Res Clin Obstet Gynaecol. 2018; 53:60-72. DOI: 10.1016/j.bpobgyn.2018.06.004. View

15.

Norris R, Freudzon L, Freudzon M, Hand A, Mehlmann L, Jaffe L . A G(s)-linked receptor maintains meiotic arrest in mouse oocytes, but luteinizing hormone does not cause meiotic resumption by terminating receptor-G(s) signaling. Dev Biol. 2007; 310(2):240-9. PMC: 2311505. DOI: 10.1016/j.ydbio.2007.07.017. View

16.

Hreinsson J, Rosenlund B, Friden B, Levkov L, Ek I, Suikkari A . Recombinant LH is equally effective as recombinant hCG in promoting oocyte maturation in a clinical in-vitro maturation programme: a randomized study. Hum Reprod. 2003; 18(10):2131-6. DOI: 10.1093/humrep/deg422. View

17.

Walls M, Junk S, Ryan J, Hart R . IVF versus ICSI for the fertilization of in-vitro matured human oocytes. Reprod Biomed Online. 2012; 25(6):603-7. DOI: 10.1016/j.rbmo.2012.08.001. View

18.

Conti M, Franciosi F . Acquisition of oocyte competence to develop as an embryo: integrated nuclear and cytoplasmic events. Hum Reprod Update. 2018; 24(3):245-266. PMC: 5907346. DOI: 10.1093/humupd/dmx040. View

19.

Son W, Park S, Lee K, Lee W, Ko J, Yoon T . Effects of 1,2-propanediol and freezing-thawing on the in vitro developmental capacity of human immature oocytes. Fertil Steril. 1996; 66(6):995-9. DOI: 10.1016/s0015-0282(16)58696-8. View

20.

Mikkelsen A, Smith S, Lindenberg S . In-vitro maturation of human oocytes from regularly menstruating women may be successful without follicle stimulating hormone priming. Hum Reprod. 1999; 14(7):1847-51. DOI: 10.1093/humrep/14.7.1847. View